Giulia Bottai
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 9
- MicroRNA in disease regulation 6
- Cancer Genomics and Diagnostics 3
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Libero Santarpia (20 shared papers)Balázs Győrffy (8 shared papers)Gyöngyi Munkácsy (3 shared papers)Ádám M. Nagy (1 shared paper)András Szabó (1 shared paper)András Lánczky (1 shared paper)George A. Călin (5 shared papers)Anne‐Lise Børresen‐Dale (3 shared papers)
- Journals
- Current Pharmaceutical Design (2 papers)Breast Cancer Research and Treatment (2 papers)Expert Opinion on Biological Therapy (2 papers)The Oncologist (2 papers)Oncotarget (1 paper)
- Partner nations
- ItalyUnited StatesHungary
In The Last Decade
Giulia Bottai
24 papers receiving 1.9k citations
Giulia Bottai's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 915
- Oncology 425
- Molecular Biology 475
- Hepatology 40
- Pulmonary and Respiratory Medicine 138
Countries citing papers authored by Giulia Bottai
This map shows the geographic impact of Giulia Bottai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Bottai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Bottai more than expected).
Fields of papers citing papers by Giulia Bottai
This network shows the impact of papers produced by Giulia Bottai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Bottai. The network helps show where Giulia Bottai may publish in the future.
Co-authors
The 25 scholars most cited alongside Giulia Bottai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients Hit paper breakdown → | 2016 | 612 |
| 2 | 2014 | 199 | |
| 3 | 2016 | 157 | |
| 4 | 2015 | 144 | |
| 5 | 2015 | 136 | |
| 6 | 2012 | 100 | |
| 7 | 2016 | 94 | |
| 8 | 2013 | 73 | |
| 9 | 2014 | 62 | |
| 10 | 2016 | 50 | |
| 11 | 2016 | 48 | |
| 12 | 2016 | 43 | |
| 13 | 2017 | 39 | |
| 14 | 2014 | 38 | |
| 15 | 2012 | 37 | |
| 16 | 2017 | 36 | |
| 17 | 2018 | 25 | |
| 18 | 2017 | 16 | |
| 19 | 2018 | 14 | |
| 20 | 2020 | 10 |
About Giulia Bottai
Giulia Bottai is a scholar working on Cancer Research, Oncology, Genetics, Pathology and Forensic Medicine and Dermatology, having authored 24 papers that have together received 2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), MicroRNA in disease regulation (6 papers), Cancer Genomics and Diagnostics (3 papers), Epigenetics and DNA Methylation (2 papers), BRCA gene mutations in cancer (2 papers), Cancer Mechanisms and Therapy (2 papers), HER2/EGFR in Cancer Research (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Cancer Research (915 citations), Oncology (425 citations), Molecular Biology (475 citations), Hepatology (40 citations) and Pulmonary and Respiratory Medicine (138 citations). Giulia Bottai has collaborated with scholars based in Italy, United States and Hungary. Frequent co-authors include Libero Santarpia, Balázs Győrffy, Gyöngyi Munkácsy, Ádám M. Nagy, András Szabó, András Lánczky, George A. Călin, Anne‐Lise Børresen‐Dale, Laura Paladini and Carlotta Raschioni. Their work appears in journals such as Current Pharmaceutical Design, Breast Cancer Research and Treatment, Expert Opinion on Biological Therapy, The Oncologist and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.